SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is seeing elevated trading volume and renewed buyout speculation as investors track a shift toward capital-efficient partnerships following the closure of its internal discovery facility. The community remains focused on potential M&A catalysts, robust Orladeyo sales, and the significant short interest that traders believe could fuel a sharp rally if positive news emerges.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is trending amid heightened speculation surrounding potential legislative progress, including the Clarity Act, and ongoing community debate over institutional adoption in Japan and the potential for a short squeeze. Investors remain polarized, with many aggressively accumulating on dips while others express deep skepticism and frustration regarding prolonged price stagnation.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending following a massive $19 billion, 20-year lease agreement with AI giant Anthropic for its Kentucky data center campus, a deal that signals the companys definitive pivot from crypto mining to critical AI infrastructure. While the community is debating whether the stock's volatile price action reflects a 'sell-the-news' event or aggressive institutional manipulation, long-term investors remain highly optimistic about TeraWulf's status as a top-tier power provider for the AI sector.

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the development of imdusiran (AB-729), proprietary, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic, and AB-101, proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). The company was founded on October 6, 2005 and is headquartered in Warminster, PA.

Arbutus Biopharma Corp

Arbutus Biopharma is trending as investors focus on the FDA Fast Track designation for its lead hepatitis B candidate, imdusiran, while continuing to speculate on the potential for a multibillion-dollar patent settlement with Pfizer. Community discussion remains heavily centered on institutional accumulation, the stock's significant undervaluation relative to its IP portfolio, and frustration over prolonged periods of price consolidation despite positive clinical and legal developments.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing heightened community interest as investors weigh its potential for a short squeeze against significant options activity and ongoing consolidation near technical support levels. While sentiment remains polarized between bulls anticipating a breakout from its recent trading range and skeptics citing lack of immediate catalysts, discourse is heavily focused on the stock's high short interest and its strategic positioning in the AI and robotics sectors.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as the market reacts to a 75-million-share offering designed to strengthen the balance sheet and satisfy equity-matching requirements for a government loan for its Georgia manufacturing plant. While the company simultaneously reported a positive revenue forecast, the community is sharply divided, with bulls viewing the capital raise as a strategic move to unlock long-term growth and bears expressing frustration over the timing and resulting share dilution.

Phoenix Asia Holdings Ltd. engages in the substructure works and other construction services. It offers site formation, ground investigation and foundation work through it subsidiary. The company was founded on August 9, 2024 and is headquartered in Hong Kong.

Phoenix Asia Holdings Ltd.

Phoenix Asia Holdings is capturing significant investor attention as community members trade the stock based on its history of volatile, low-float price swings and frequent volatility halts. Discussions are currently dominated by retail traders debating the stock's potential for explosive squeezes versus skepticism over its long-term stability and underlying business performance.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending as investors focus on the potential for massive valuation expansion driven by the clinical progress of its Briumvi franchise into new indications like myasthenia gravis and schizophrenia. The community is actively discussing a potential buyout and expressing strong frustration with skeptical analyst ratings, fueling a battle between retail longs expecting a major premium and shorts betting on market volatility.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions is trending following a massive Q3 earnings beat and raised full-year guidance, with investors highlighting its critical role in the AI infrastructure and memory demand ecosystem. Community discussion is focused on the stock's positioning as an NVIDIA AI Factory partner, though some traders remain cautious regarding recent share dilution and dependency on memory pricing cycles.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Advanced Micro Devices is trending as investors react to bullish price target hikes from Goldman Sachs and Cantor Fitzgerald, with the stock nearing a one-trillion-dollar market cap driven by data center and AI infrastructure demand. While the community is actively debating the stock's valuation and the potential for a tech rotation, bullish sentiment remains centered on the upcoming Advancing AI event and strong institutional interest in the company's long-term AI pipeline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

WinVest Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. The company was founded by Manish Jhunjhunwala and Jeff LeBlanc on March 1, 2021 and is headquartered in Cambridge, MA.

WinVest Acquisition Corp

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

WINVWinVest Acquisition Corp

Fundamentals

Latest WINV News